推动代表性不足的女性参与临床研究。

Advancing the inclusion of underrepresented women in clinical research.

机构信息

Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard, Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA.

Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard, Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.

出版信息

Cell Rep Med. 2022 Mar 7;3(4):100553. doi: 10.1016/j.xcrm.2022.100553. eCollection 2022 Apr 19.

DOI:10.1016/j.xcrm.2022.100553

PMID:35492242

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9043984/

Abstract

Women, and specifically women of color, are underrepresented in clinical trials, limiting biological understanding and contributing to health inequities and social injustice. Analyses of barriers to inclusion suggest practical interventions that together create a roadmap of specific and actionable steps to increase diverse representation in research and sustainable change.

摘要

女性，特别是有色人种女性，在临床试验中代表性不足，这限制了对生物学的理解，并导致了健康不平等和社会不公正。对纳入障碍的分析表明，可以采取切实可行的干预措施，共同制定具体和可操作的步骤，以增加研究和可持续变革中的多样性代表性。